Latest / Systemic Error Podcast
Mysterious request for unapproved drug raising questions about Trump’s health
Compassionate Use for the PowerfulNot a drug storyThis is not mainly a story about retatrutide. It is a story about who gets the state, the NIH, and the FDA to bend around their needs while everyone else waits for approval, paperwork, and denial.STAT reports that a 79-year-old man gained access to Eli Lilly’s experimental weight-loss drug through the FDA’s “compassionate use” pathway in April. Sources pointed to Donald Trump, who was 79 at the time and turned 80 in June. The White House would not answer directly, and the official medical memo it pointed to did not mention the conditions cited…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.